Nureca Price to Sales Ratio (P/S)

Nureca Ltd Price to Sales Ratio

The Nureca Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Nureca Ltd's valuation, profitability, and overall financial performance. Tracking the Nureca Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Nureca Ltd (NSE: NURECA, BSE: 543264) is currently trading at ₹295.20, with a market capitalization of ₹2.8B. As a leading company in the Health technology sector and Medical specialties industry, monitoring the Nureca Ltd Price to Sales Ratio is essential for fundamental analysis.

Nureca Ltd Price to Sales Ratio Current Value

The current Nureca Ltd Price to Sales Ratio stands at 1.92.

The Nureca Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Nureca Ltd Price to Sales Ratio Historical Trend

The Nureca Ltd Price to Sales Ratio has shown the following historical trend:

• 2024: 1.92
• 2023: 2.78
• 2022: 2.70
• 2021: 5.33
• 2020: 2.11

The decline in Nureca Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.

What Nureca Ltd Price to Sales Ratio Indicates for Investors

The Nureca Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Nureca Ltd Price to Sales Ratio Analysis Summary

The Nureca Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Nureca Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Nureca Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.